Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Pancreatic Fibrosis as a Prognostic Factor of Its Course

NCT05775107 is registered in ClinicalTrials.gov with Moscow Clinical Scientific Center as lead sponsor.

NCT NCT05775107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05775107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Pancreatic Fibrosis as a Prognostic Factor of Its Course
Lead sponsor
Moscow Clinical Scientific Center
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 1, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic fibrosis